Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1980 1
1985 3
1987 2
1990 1
1995 1
1996 2
1997 2
1998 3
2000 2
2001 1
2002 6
2003 10
2004 7
2005 9
2006 6
2007 10
2008 9
2009 10
2010 7
2011 3
2012 7
2013 11
2014 11
2015 10
2016 10
2017 2
2018 5
2019 2
2020 6
2021 5
2022 10
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Results by year

Filters applied: . Clear all
Page 1
Single-cell RNA sequencing identifies a population of human liver-type ILC1s.
Krämer B, Nalin AP, Ma F, Eickhoff S, Lutz P, Leonardelli S, Goeser F, Finnemann C, Hack G, Raabe J, ToVinh M, Ahmad S, Hoffmeister C, Kaiser KM, Manekeller S, Branchi V, Bald T, Hölzel M, Hüneburg R, Nischalke HD, Semaan A, Langhans B, Kaczmarek DJ, Benner B, Lordo MR, Kowalski J, Gerhardt A, Timm J, Toma M, Mohr R, Türler A, Charpentier A, van Bremen T, Feldmann G, Sattler A, Kotsch K, Abdallah AT, Strassburg CP, Spengler U, Carson WE 3rd, Mundy-Bosse BL, Pellegrini M, O'Sullivan TE, Freud AG, Nattermann J. Krämer B, et al. Among authors: gerhardt a. Cell Rep. 2023 Jan 31;42(1):111937. doi: 10.1016/j.celrep.2022.111937. Epub 2023 Jan 1. Cell Rep. 2023. PMID: 36640314 Free PMC article.
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
Pfisterer J, Shannon CM, Baumann K, Rau J, Harter P, Joly F, Sehouli J, Canzler U, Schmalfeldt B, Dean AP, Hein A, Zeimet AG, Hanker LC, Petit T, Marmé F, El-Balat A, Glasspool R, de Gregorio N, Mahner S, Meniawy TM, Park-Simon TW, Mouret-Reynier MA, Costan C, Meier W, Reinthaller A, Goh JC, L'Haridon T, Baron Hay S, Kommoss S, du Bois A, Kurtz JE; AGO-OVAR 2.21/ENGOT-ov 18 Investigators. Pfisterer J, et al. Lancet Oncol. 2020 May;21(5):699-709. doi: 10.1016/S1470-2045(20)30142-X. Epub 2020 Apr 16. Lancet Oncol. 2020. PMID: 32305099 Clinical Trial.
A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability.
Voigt EA, Gerhardt A, Hanson D, Jennewein MF, Battisti P, Reed S, Singh J, Mohamath R, Bakken J, Beaver S, Press C, Soon-Shiong P, Paddon CJ, Fox CB, Casper C. Voigt EA, et al. Among authors: gerhardt a. NPJ Vaccines. 2022 Nov 2;7(1):136. doi: 10.1038/s41541-022-00549-y. NPJ Vaccines. 2022. PMID: 36323666 Free PMC article.
Authors' response.
Tesarz J, Gerhardt A, Treede RD, Eich W. Tesarz J, et al. Among authors: gerhardt a. Pain. 2013 Dec;154(12):2888-2890. doi: 10.1016/j.pain.2013.10.018. Epub 2013 Oct 21. Pain. 2013. PMID: 24157895 No abstract available.
Development and Testing of a Spray-Dried Tuberculosis Vaccine Candidate in a Mouse Model.
Gomez M, Ahmed M, Das S, McCollum J, Mellett L, Swanson R, Gupta A, Carrigy NB, Wang H, Barona D, Bachchhav S, Gerhardt A, Press C, Archer MC, Liang H, Seydoux E, Kramer RM, Kuehl PJ, Vehring R, Khader SA, Fox CB. Gomez M, et al. Among authors: gerhardt a. Front Pharmacol. 2022 Jan 21;12:799034. doi: 10.3389/fphar.2021.799034. eCollection 2021. Front Pharmacol. 2022. PMID: 35126135 Free PMC article.
Interactions between effects of environmental chemicals and natural stressors: a review.
Holmstrup M, Bindesbøl AM, Oostingh GJ, Duschl A, Scheil V, Köhler HR, Loureiro S, Soares AM, Ferreira AL, Kienle C, Gerhardt A, Laskowski R, Kramarz PE, Bayley M, Svendsen C, Spurgeon DJ. Holmstrup M, et al. Among authors: gerhardt a. Sci Total Environ. 2010 Aug 15;408(18):3746-62. doi: 10.1016/j.scitotenv.2009.10.067. Epub 2009 Nov 17. Sci Total Environ. 2010. PMID: 19922980 Review.
Author Correction: A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability.
Voigt EA, Gerhardt A, Hanson D, Jennewein MF, Battisti P, Reed S, Singh J, Mohamath R, Bakken J, Beaver S, Press C, Soon-Shiong P, Paddon CJ, Fox CB, Casper C. Voigt EA, et al. Among authors: gerhardt a. NPJ Vaccines. 2022 Nov 23;7(1):150. doi: 10.1038/s41541-022-00578-7. NPJ Vaccines. 2022. PMID: 36418864 Free PMC article. No abstract available.
163 results